We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$6.39B
AUM Growth
+$1.46B
Cap. Flow
+$813M
Cap. Flow %
12.72%
Top 10 Hldgs %
30%
Holding
130
New
34
Increased
32
Reduced
37
Closed
15

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$114M
2
CNC icon
Centene
CNC
+$75.1M
3
ESPR
Esperion Therapeutics
ESPR
+$67.2M
4
SPOT icon
Spotify
SPOT
+$55.4M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$51.4M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$198M
2
MSFT icon
Microsoft
MSFT
+$102M
3
BAX icon
Baxter International
BAX
+$84.8M
4
MOH icon
Molina Healthcare
MOH
+$65.2M
5
UNH icon
UnitedHealth
UNH
+$50.1M

Sector Composition

Rank Sector Weight
1 Healthcare 48.69%
2 Technology 9.35%
3 Communication Services 7.21%
4 Consumer Discretionary 2.57%
5 Financials 2.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOLX
26
DELISTED
Hologic
HOLX
$75.2M 1.18%
1,892,703
+319,846
+20% +$12.3M
MMSI icon
27
Merit Medical Systems
MMSI
$4.43B
$74.5M 1.17%
1,455,616
+598,822
+70% +$29.7M
UNH icon
28
UnitedHealth
UNH
$382B
$74.3M 1.16%
302,688
-208,583
-41% -$50.1M
BABA icon
29
Alibaba
BABA
$269B
$73.8M 1.16%
397,786
+118,285
+42% +$22.5M
EW icon
30
Edwards Lifesciences
EW
$47.6B
$73.3M 1.15%
1,509,735
-170,250
-10% -$7.95M
ONCE
31
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$72.6M 1.14%
876,779
+239,143
+38% +$18.5M
HRTX icon
32
PUT
Heron Therapeutics
HRTX
$86.3M
$69.1M 1.08%
+1,777,500
New +$56.6M
GDDY icon
33
GoDaddy
GDDY
$12.3B
$68.9M 1.08%
975,419
-323,641
-25% -$22M
A icon
34
Agilent Technologies
A
$39.1B
$68.8M 1.08%
1,113,069
+249,400
+29% +$16.3M
BAX icon
35
Baxter International
BAX
$11.6B
$63.9M 1%
865,121
-1,202,711
-58% -$84.8M
ACOR
36
DELISTED
Acorda Therapeutics
ACOR
$62M 0.97%
18,006
-9,954
-36% -$30.5M
INTU icon
37
Intuit
INTU
$81.1B
$61M 0.96%
298,586
+59,735
+25% +$11.5M
SPOT icon
38
Spotify
SPOT
$99.2B
$58.3M 0.91%
+346,510
New +$55.4M
DATA
39
DELISTED
Tableau Software, Inc.
DATA
$57.7M 0.9%
590,458
-205,915
-26% -$18.9M
ICLR icon
40
Icon
ICLR
$12.8B
$57.3M 0.9%
432,312
+163,959
+61% +$20.4M
ECYT
41
DELISTED
Endocyte, Inc. Common Stock
ECYT
$56.1M 0.88%
4,068,608
-270,636
-6% -$3.21M
HCA icon
42
HCA Healthcare
HCA
$84.8B
$53.6M 0.84%
522,345
-63,106
-11% -$6.38M
BPMC
43
DELISTED
Blueprint Medicines
BPMC
$53.6M 0.84%
844,081
-73,909
-8% -$5.88M
MOH icon
44
Molina Healthcare
MOH
$10.3B
$52.7M 0.83%
537,962
-748,436
-58% -$65.2M
ARNA
45
DELISTED
Arena Pharmaceuticals Inc
ARNA
$52.2M 0.82%
+1,196,891
New +$51.4M
AGIO icon
46
Agios Pharmaceuticals
AGIO
$2.16B
$51.8M 0.81%
614,506
-62,585
-9% -$5.46M
TWTR
47
DELISTED
Twitter, Inc.
TWTR
$51.2M 0.8%
1,172,793
-702,066
-37% -$24.6M
AMZN icon
48
Amazon
AMZN
$2.5T
$51.1M 0.8%
601,140
-15,660
-3% -$1.24M
DBX icon
49
Dropbox
DBX
$6.81B
$49.6M 0.78%
1,529,689
+848,387
+125% +$26.5M
MSGS icon
50
Madison Square Garden
MSGS
$9.54B
$48.9M 0.77%
+221,151
New +$40.9M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2018 Portfolio in Review

As of Q2 2018, PFM Health Sciences held 130 positions worth $6.39B, up 30% from $4.92B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

PFM Health Sciences deployed $813M of net new capital in Q2 2018, opening 34 new positions and adding to 32 existing holdings. Its largest new stake was Clovis Oncology, Inc.: 2,337,225 shares worth $106M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 60% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Microsoft, an estimated $102M trimmed.

  • PFM Health Sciences's largest Q2 2018 buy was Clovis Oncology, Inc.: 2,337,225 shares worth $106M.
  • PFM Health Sciences added most to Esperion Therapeutics in Q2 2018, an estimated $67.2M increase.
  • PFM Health Sciences's biggest Q2 2018 reduction was Microsoft, cutting an estimated $102M.
  • PFM Health Sciences fully exited Bristol-Myers Squibb in Q2 2018, selling an estimated $198M.
  • PFM Health Sciences's ten largest holdings make up 30% of its $6.39B portfolio in Q2 2018.
  • PFM Health Sciences opened 34 new positions and closed 15 in Q2 2018.
  • PFM Health Sciences's portfolio value rose 30% quarter-over-quarter to $6.39B.

Based on PFM Health Sciences's 13F filing for Q2 2018, filed 14 Aug 2018.